A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia
Status:
Terminated
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
This pilot study will assess the safety and efficacy of Pivanex alone in patients with
chronic lymphocytic leukemia (CLL) who have relapsed or refractory disease after previous
chemotherapy treatment. Pivanex is an investigational agent.